IRON AMINOS GLP-3 RETA 60MG
Research-grade incretin-pathway material prepared for consistency and clear documentation in professional lab workflows.
Key Features
-
60mg GLP-3 RETA per vial (lyophilized powder)
-
≥99% purity for reproducible results
-
Sterile, sealed glass vial with tamper-evident flip cap
-
Lot/batch labeling for traceability
-
Signature Iron Aminos red honeycomb label for quick identification
-
Diluent not included
Specifications
-
Compound: GLP-3 RETA
-
Class: Triple receptor agonist research category (GLP-1, GIP, glucagon)
-
Form / appearance: Lyophilized powder, white to off-white
-
Amount: 60mg per vial
-
Purity: ≥99%
-
Storage (lyophilized): Cool, dry, away from light
-
Storage (after reconstitution): Refrigerate; use promptly per internal SOP
What’s Included
-
1 × GLP-3 RETA 60mg vial (no diluent)
Handling
Use an appropriate sterile diluent and aseptic technique. Follow your lab’s SOPs for reconstitution, aliquoting, labeling, and disposal.
Research Snapshot
-
Triple-agonist compounds in this class have shown large body-weight reductions in randomized studies when paired with diet guidance and structured dose escalation.
-
In type-2 diabetes research settings, the class demonstrates meaningful HbA1c reductions alongside weight effects and improvements in select metabolic markers.
-
Common study-reported adverse events are gastrointestinal (nausea, vomiting, diarrhea) and are typically dose-dependent; gradual titration is often used to improve tolerability.
-
GLP-3 RETA here is investigational and supplied strictly for laboratory research; findings are model- and protocol-dependent.
Compliance
For research use only. Not for human consumption.
Not a drug, food, or cosmetic and not intended to diagnose, treat, cure, or prevent any disease.
